A study on the effect of unani formulation in leucorrhoea at adolescent age group

A single armed single center clinical study to evaluate therapeutic efficacy and safety of unani formulation in sayalan al rahim (leucorrhoea)at adolescent age group - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/083659

Enrollment

Registered

2025-03-28

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N899- Noninflammatory disorder of vagina, unspecified

Interventions

Intervention1: 1.Gul-e-dhawa(woodfordia fruticosa) 2.Gul-e-fofil(Areca catechu linn) 3.Mocharas(bombax malabaricum) 4.Gond mulsari(Mimusops elengi linn) : Patient will be given 6 gm of above mentioned

Eligibility

Inclusion criteria

Inclusion criteria: Leucorrhea diagnosis based on following symptoms 1.Excessive White or Creamy vaginal discharge evident from persistent vulvar moistness or staining of the undergarments(brownish-yellow stain on drying)or need to wear a vulvar pad,with or without any of the following symptoms 2.low backaches 3.generalised weakness

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
1.To reduce vaginal white dischargeTimepoint: 12 weeks	—

Secondary

Measure	Time frame
1.To reduce associated symptoms eg.pruritus vulva,lower abdominal pain,burning sensationTimepoint: 12 weeks	—

Countries

India

Contacts

Public ContactDr shahzadi Sultana

Government nizamia tibbi college and general hospital

drssntc@gmail.com9908624090

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026